The NHS bowel cancer screening programme is detecting approximately 100 cancers every week, according to annual statistics published by NHS England covering the period from April 2024 to March 2025. The figures have prompted health officials to draw attention to a persistent gap in participation among people in their 50s, who are returning their at-home screening kits at lower rates than older age groups.
What the Data Shows
Among the specific age groups examined in the NHS England release, 54-year-olds recorded a participation rate of 56.2% during the 2024–25 reporting year. That figure sits below the rates seen in older cohorts who are also invited to take part in the programme, suggesting that the earliest eligible age groups are less likely to follow through with the test once a kit arrives.
The programme works by sending a home testing kit — known as a faecal immunochemical test, or FIT — through the post. Individuals collect a small stool sample and return it for laboratory analysis. A positive result triggers a referral for further investigation, typically a colonoscopy.
Why Participation Rates Matter
Bowel cancer is among the most common cancers diagnosed in England, and outcomes are strongly linked to the stage at which the disease is caught. Screening is designed to identify abnormalities before symptoms develop, when treatment is generally more straightforward. The weekly detection figure of roughly 100 cancers through the programme alone underscores the volume of cases that might otherwise go unnoticed until a later, harder-to-treat stage.
The lower uptake recorded among people in their 50s is a recognised challenge for screening programmes more broadly. Individuals newly entering an eligible age group may be less familiar with the process, or may underestimate personal risk at a relatively younger age compared with those in their 60s or 70s. Public health researchers have previously noted that first-time invitees to any screening programme tend to show lower response rates than those who have participated in prior rounds.
The Screening Programme's Reach
England's bowel screening programme has been gradually expanding its eligible age range in recent years, with the lower threshold having been extended to include those in their 50s. That expansion was intended to catch cancers and pre-cancerous polyps earlier, but it also means a larger cohort of first-time participants who may not yet have established the habit of returning kits.
The NHS England data release does not break down non-participation by reason, so it is not possible from the published figures alone to distinguish between those who received a kit and chose not to return it and those who may have encountered logistical barriers. Research published in journals including the British Journal of Cancer has previously identified factors such as kit anxiety, low health literacy, and practical difficulties with sample collection as contributors to non-return in similar programmes internationally.
Context for the 100-Per-Week Figure
The headline statistic — around 100 bowel cancers identified through screening each week — reflects the programme's output across all participating age groups, not solely those in their 50s. It represents a substantial absolute number of diagnoses that, by definition, were made in individuals who had not yet presented to a clinician with symptoms. Whether each of those cases would have been detected sooner, later, or at a comparable stage without screening is a question the aggregate figure cannot answer, though the established evidence base for FIT-based screening programmes generally supports a stage-shift toward earlier detection.
NHS England's publication of these figures forms part of routine annual reporting on cancer screening performance across the health service. The full dataset, including breakdowns by region and age band, is available through the NHS England statistical release accompanying the announcement.